NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-lambda B signaling

dc.contributor.authorCoutermarsh-Ott, Sherylen
dc.contributor.authorSimmons, Alyshaen
dc.contributor.authorCapria, Vittoriaen
dc.contributor.authorLeRoith, Tanyaen
dc.contributor.authorWilson, Justin E.en
dc.contributor.authorHeid, Bettinaen
dc.contributor.authorPhilipson, Casandra W.en
dc.contributor.authorQin, Q.en
dc.contributor.authorHontecillas, Raquelen
dc.contributor.authorBassaganya-Riera, Josepen
dc.contributor.authorTing, Jenny P.-Y.en
dc.contributor.authorDervisis, Nikolaos G.en
dc.contributor.authorAllen, Irving C.en
dc.contributor.departmentBiological Sciencesen
dc.contributor.departmentSmall Animal Clinical Sciencesen
dc.date.accessioned2016-11-15T20:47:06Zen
dc.date.available2016-11-15T20:47:06Zen
dc.date.issued2016-05-31en
dc.description.versionPublished versionen
dc.format.extent33096 - 33110 (15) page(s)en
dc.format.mimetypeapplication/pdfen
dc.identifier.doihttps://doi.org/10.18632/oncotarget.8861en
dc.identifier.issn1949-2553en
dc.identifier.issue22en
dc.identifier.urihttp://hdl.handle.net/10919/73447en
dc.identifier.volume7en
dc.language.isoenen
dc.publisherImpact Journalsen
dc.relation.urihttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000377748500116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=930d57c9ac61a043676db62af60056c1en
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.subjectOncologyen
dc.subjectCell Biologyen
dc.subjectNLRen
dc.subjectNod-like receptoren
dc.subjecturethaneen
dc.subjectcanceren
dc.subjectinflammationen
dc.subjectINFLAMMATORY-BOWEL-DISEASEen
dc.subjectNONSMALL CELL LUNGen
dc.subjectTUMOR-SUPPRESSORen
dc.subjectCOLON TUMORIGENESISen
dc.subjectI INTERFERONen
dc.subjectCANCER-CELLSen
dc.subjectPATHWAYen
dc.subjectPROTEINen
dc.subjectGROWTHen
dc.subjectCARCINOGENESISen
dc.titleNLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-lambda B signalingen
dc.title.serialOncoTargeten
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten
pubs.organisational-group/Virginia Techen
pubs.organisational-group/Virginia Tech/All T&R Facultyen
pubs.organisational-group/Virginia Tech/Faculty of Health Sciencesen
pubs.organisational-group/Virginia Tech/University Research Institutesen
pubs.organisational-group/Virginia Tech/University Research Institutes/Biocomplexity Instituteen
pubs.organisational-group/Virginia Tech/University Research Institutes/Biocomplexity Institute/Researchersen
pubs.organisational-group/Virginia Tech/University Research Institutes/Biocomplexity Institute/SelectedFaculty1en
pubs.organisational-group/Virginia Tech/Veterinary Medicineen
pubs.organisational-group/Virginia Tech/Veterinary Medicine/CVM T&R Facultyen
pubs.organisational-group/Virginia Tech/Veterinary Medicine/Small Animal Clinical Sciencesen

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling.pdf
Size:
25.44 MB
Format:
Adobe Portable Document Format
Description:
Publisher's Version
License bundle
Now showing 1 - 1 of 1
Name:
VTUL_Distribution_License_2016_05_09.pdf
Size:
18.09 KB
Format:
Adobe Portable Document Format
Description: